- Home
- THTX vs COYA Comparison
THTX vs COYA Comparison
Compare THTX & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- COYA
- Stock Information
- Founded
- THTX 1993
- COYA 2020
- Country
- THTX Canada
- COYA United States
- Employees
- THTX N/A
- COYA N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- THTX Health Care
- COYA Health Care
- Exchange
- THTX Nasdaq
- COYA Nasdaq
- Market Cap
- THTX 118.2M
- COYA 103.2M
- IPO Year
- THTX N/A
- COYA 2022
- Fundamental
- Price
- THTX $2.62
- COYA $6.05
- Analyst Decision
- THTX Hold
- COYA Strong Buy
- Analyst Count
- THTX 1
- COYA 4
- Target Price
- THTX N/A
- COYA $17.00
- AVG Volume (30 Days)
- THTX 6.2M
- COYA 68.3K
- Earning Date
- THTX 04-09-2025
- COYA 05-16-2025
- Dividend Yield
- THTX N/A
- COYA N/A
- EPS Growth
- THTX N/A
- COYA N/A
- EPS
- THTX N/A
- COYA N/A
- Revenue
- THTX $88,666,000.00
- COYA $3,554,061.00
- Revenue This Year
- THTX N/A
- COYA $94.45
- Revenue Next Year
- THTX $15.13
- COYA N/A
- P/E Ratio
- THTX N/A
- COYA N/A
- Revenue Growth
- THTX 13.52
- COYA N/A
- 52 Week Low
- THTX $1.08
- COYA $4.65
- 52 Week High
- THTX $3.13
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- THTX 57.56
- COYA 49.30
- Support Level
- THTX $2.64
- COYA $5.77
- Resistance Level
- THTX $2.82
- COYA $6.59
- Average True Range (ATR)
- THTX 0.17
- COYA 0.54
- MACD
- THTX -0.04
- COYA 0.01
- Stochastic Oscillator
- THTX 20.45
- COYA 24.81
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.